The stimulation of CD8+ T cells by dendritic cells pulsed with polyketal microparticles containing ion-paired protein antigen and poly(inosinic acid)-poly(cytidylic acid).

New adjuvants and delivery strategies are needed to optimize the ability of protein-based vaccines to elicit CD8(+) T cell responses. We have developed a model vaccine formulation containing ovalbumin (OVA) and the double-stranded RNA analog poly(inosinic acid)-poly(cytidylic acid) (poly(I:C)), a TLR3 agonist. OVA and poly(I:C) were each ion-paired to cetyltrimethylammonium bromide (CTAB) to produce hydrophobic complexes, which were co-encapsulated in pH-sensitive polyketal (PK3) microparticles (1-3 microm) using a single emulsion method. Loading levels ranged from 13.6 to 18.8 microg/mg OVA and 4.8 to 10.3 microg/mg poly(I:C). Murine splenic dendritic cells (DCs) pulsed with PK3-OVA-poly(I:C) microparticles, at antigen doses of 0.01 and 0.1 microg/mL, induced a higher percentage of IFNgamma-producing CD8(+) T cells than DCs treated with PK3-OVA particles or soluble OVA/poly(I:C). A higher antigen dose (1 microg/mL) was less effective, which can be attributed to CTAB toxicity. At the lowest antigen dose (0.01 microg/mL), PK3-OVA-poly(I:C) microparticles also enhanced TNF-alpha and IL-2 production in CD8(+) T cells. These data demonstrate the potential of polyketal microparticles in formulating effective CD8(+) T cell-inducing vaccines comprising protein antigens and dsRNA adjuvants.

[1]  S. Akira,et al.  A Subset of Toll-Like Receptor Ligands Induces Cross-presentation by Bone Marrow-Derived Dendritic Cells1 , 2003, The Journal of Immunology.

[2]  R. Flavell,et al.  Toll-like receptor 3 promotes cross-priming to virus-infected cells , 2005, Nature.

[3]  A. Alshamsan,et al.  Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles. , 2007, Journal of biomedical materials research. Part A.

[4]  Antonio Lanzavecchia,et al.  Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells , 2001, European journal of immunology.

[5]  R. Flavell,et al.  Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.

[6]  A. Iwasaki,et al.  Toll-like receptor control of the adaptive immune responses , 2004, Nature Immunology.

[7]  Kristin A. Hogquist,et al.  T cell receptor antagonist peptides induce positive selection , 1994, Cell.

[8]  T. Burke,et al.  The Acidic Microclimate in Poly(lactide-co-glycolide) Microspheres Stabilizes Camptothecins , 1999, Pharmaceutical Research.

[9]  U. Le,et al.  Nasal immunization with the mixture of PA63, LF, and a PGA conjugate induced strong antibody responses against all three antigens. , 2008, FEMS immunology and medical microbiology.

[10]  R. Langer,et al.  A potential approach for decreasing the burst effect of protein from PLGA microspheres. , 2003, Journal of pharmaceutical sciences.

[11]  T. Giese,et al.  Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help. , 2004, Blood.

[12]  M. Bevan,et al.  Effector and memory CTL differentiation. , 2007, Annual review of immunology.

[13]  R. Gurny,et al.  Comparison of two methods of encapsulation of an oligonucleotide into poly(D,L-lactic acid) particles. , 2001, International journal of pharmaceutics.

[14]  Susumu Tonegawa,et al.  RAG-1-deficient mice have no mature B and T lymphocytes , 1992, Cell.

[15]  R. Medzhitov,et al.  Toll-dependent selection of microbial antigens for presentation by dendritic cells , 2006, Nature.

[16]  N. Murthy,et al.  Polyketal nanoparticles: a new pH-sensitive biodegradable drug delivery vehicle. , 2005, Bioconjugate chemistry.

[17]  Robert H Pierce,et al.  Polyketal copolymers: a new acid-sensitive delivery vehicle for treating acute inflammatory diseases. , 2008, Bioconjugate chemistry.

[18]  B. Pulendran.  Variegation of the Immune Response with Dendritic Cells and Pathogen Recognition Receptors1 , 2005, The Journal of Immunology.

[19]  M. Jan,et al.  Cytotoxicity characterization of catanionic vesicles in RAW 264.7 murine macrophage-like cells. , 2005, Colloids and surfaces. B, Biointerfaces.

[20]  R. Koup,et al.  Toll-Like Receptor Ligands Modulate Dendritic Cells to Augment Cytomegalovirus- and HIV-1-Specific T Cell Responses 1 , 2003, The Journal of Immunology.

[21]  J. Davis,et al.  Immune system activation and fatigue during treadmill running: role of interferon. , 1998, Medicine and science in sports and exercise.

[22]  Colm Cunningham,et al.  The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C) , 2007, Brain, Behavior, and Immunity.

[23]  M. Hirose,et al.  Thermostabilization of Ovalbumin in a Developing Egg by an Alkalinity-regulated, Two-step Process , 2001, Bioscience, biotechnology, and biochemistry.

[24]  M. Manning,et al.  Enhanced solubility of proteins and peptides in nonpolar solvents through hydrophobic ion pairing , 1993 .

[25]  Tae Gwan Park,et al.  Biodegradable nanoparticles containing protein-fatty acid complexes for oral delivery of salmon calcitonin. , 2004, Journal of pharmaceutical sciences.

[26]  M. Roederer,et al.  T-cell quality in memory and protection: implications for vaccine design , 2008, Nature Reviews Immunology.

[27]  W. Cao,et al.  Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells. , 2006, Blood.

[28]  D. Busch,et al.  Vaccine protocols for enhanced immunogenicity of exogenous antigens. , 2008, International journal of medical microbiology : IJMM.

[29]  A. Shaw,et al.  Triggering TLR signaling in vaccination. , 2006, Trends in immunology.

[30]  A. Klibanov,et al.  Protein stability in controlled-release systems , 2000, Nature Biotechnology.

[31]  R. Misra,et al.  Biomaterials , 2008 .

[32]  M. Manning,et al.  Hydrophobic Ion Pairing: Altering the Solubility Properties of Biomolecules , 1998, Pharmaceutical Research.

[33]  R. Verdijk,et al.  Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells. , 1999, Journal of immunology.

[34]  N. Kadowaki,et al.  Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens , 2001, The Journal of experimental medicine.

[35]  D. Busch,et al.  Antigen co‐encapsulated with adjuvants efficiently drive protective T cell immunity , 2007, European journal of immunology.

[36]  H. Merkle,et al.  Microencapsulation of DNA using poly(DL-lactide-co-glycolide): stability issues and release characteristics. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[37]  R. Steinman,et al.  The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine , 2008, Proceedings of the National Academy of Sciences.

[38]  B. Pulendran.  Modulating vaccine responses with dendritic cells and Toll‐like receptors , 2004, Immunological reviews.

[39]  G. Kwon,et al.  Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo. , 2002, Journal of biomedical materials research.

[40]  S. Dow,et al.  Efficient Immunization and Cross-Priming by Vaccine Adjuvants Containing TLR3 or TLR9 Agonists Complexed to Cationic Liposomes1 , 2006, The Journal of Immunology.

[41]  Y. Bae,et al.  Novel approaches in microparticulate PLGA delivery systems encapsulating proteins , 2007 .

[42]  Claudio Nastruzzi,et al.  Effect of cationic liposome composition on in vitro cytotoxicity and protective effect on carried DNA , 1996 .

[43]  Hongfan Sun,et al.  Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro. , 2003, Vaccine.

[44]  Jeffrey B Ulmer,et al.  Targeting the innate immune response with improved vaccine adjuvants , 2005, Nature Medicine.

[45]  E. Engleman,et al.  Incorporation of CpG oligonucleotide ligand into protein-loaded particle vaccines promotes antigen-specific CD8 T-cell immunity. , 2007, Bioconjugate chemistry.

[46]  W. R. Taylor,et al.  Polyketal microparticles: a new delivery vehicle for superoxide dismutase. , 2007, Bioconjugate chemistry.

[47]  Mayank M. Patel,et al.  Degradation kinetics of high molecular weight poly(L-lactide) microspheres and release mechanism of lipid:DNA complexes. , 2004, Journal of pharmaceutical sciences.

[48]  T. Kondo,et al.  Prolonged effects of polyriboinosinic:polyribocytidylic acid on spontaneous running wheel activity and brain interferon-α mRNA in rats: a model for immunologically induced fatigue , 2003, Neuroscience.

[49]  Wenlei Jiang,et al.  Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens. , 2005, Advanced drug delivery reviews.